Literature DB >> 3953452

Usefulness of right ventricular diastolic collapse in diagnosing cardiac tamponade and comparison to pulsus paradoxus.

S Singh, L S Wann, H S Klopfenstein, A Hartz, H L Brooks.   

Abstract

To compare the sensitivity, specificity and predictive value of right ventricular (RV) diastolic collapse and pulsus paradoxus as signs of cardiac tamponade, 21 consecutive patients with pericardial effusion and suspected cardiac tamponade underwent prospective hemodynamic and echocardiographic evaluation. Simultaneous hemodynamic and echocardiographic data were obtained in all patients before and after pericardiocentesis. Cardiac tamponade was considered present when there was diastolic equilibration of the intrapericardial, right atrial and pulmonary capillary wedge pressures and elevation of these pressures to more than 10 mm Hg. RV diastolic collapse was 93% sensitive and 100% specific in diagnosing cardiac tamponade, whereas pulsus paradoxus was only 79% sensitive and 40% specific. The positive and negative predictive values of RV diastolic collapse (100% and 83%) were considerably better than pulsus paradoxus (81% and 40%) and demonstrate that RV diastolic collapse is more sensitive, specific and predictive of cardiac tamponade than is pulsus paradoxus. Serial simultaneous hemodynamic and echocardiographic observations at multiple points during pericardiocentesis in a smaller subgroup (5 patients) also suggest that the hemodynamic effects of RV diastolic collapse in cardiac tamponade are mediated by an increase in intrapericardial pressure.

Entities:  

Mesh:

Year:  1986        PMID: 3953452     DOI: 10.1016/0002-9149(86)90853-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

1.  Acute Influenza Infection Presenting with Cardiac Tamponade: A Case Report and Review of Literature.

Authors:  Yadav Pandey; Rimsha Hasan; Krishna P Joshi; Fuad J Habash; Rajani Jagana
Journal:  Perm J       Date:  2019

2.  Adolf Kussmaul: distinguished clinician and medical pioneer.

Authors:  Sara K Johnson; Ramo K Naidu; Ryan C Ostopowicz; David R Kumar; Satya Bhupathi; Joseph J Mazza; Steven H Yale
Journal:  Clin Med Res       Date:  2009-07-22

Review 3.  Pericardial Effusion and Cardiac Tamponade in the New Millennium.

Authors:  Brian D Hoit
Journal:  Curr Cardiol Rep       Date:  2017-07       Impact factor: 2.931

4.  Severe rheumatic mitral stenosis with pericardial effusion causing left ventricular tamponade.

Authors:  S W Davies; A Youhana; M Copp
Journal:  Br Heart J       Date:  1992-03

5.  Neoplastic pericardial disease: Old and current strategies for diagnosis and management.

Authors:  Chiara Lestuzzi
Journal:  World J Cardiol       Date:  2010-09-26

6.  Characteristics of neoplastic cardiac tamponade and prognosis after pericardiocentesis: a single-center study of 113 consecutive cancer patients.

Authors:  Tsugumi Takayama; Yuji Okura; Yoshinobu Okada; Keiichi Honma; Atsushi Nashimoto; Nobuaki Sato; Akira Yokoyama; Tohru Minamino
Journal:  Int J Clin Oncol       Date:  2015-02-06       Impact factor: 3.402

Review 7.  Echocardiographic Evaluation of Pericardial Effusion and Cardiac Tamponade.

Authors:  Alejandro Pérez-Casares; Sergi Cesar; Laia Brunet-Garcia; Joan Sanchez-de-Toledo
Journal:  Front Pediatr       Date:  2017-04-24       Impact factor: 3.418

Review 8.  Multimodality Imaging of Sudden Cardiac Death and Acute Complications in Acute Coronary Syndrome.

Authors:  Giuseppe Muscogiuri; Andrea Igoren Guaricci; Nicola Soldato; Riccardo Cau; Luca Saba; Paola Siena; Maria Grazia Tarsitano; Elisa Giannetta; Davide Sala; Paolo Sganzerla; Marco Gatti; Riccardo Faletti; Alberto Senatieri; Gregorio Chierchia; Gianluca Pontone; Paolo Marra; Mark G Rabbat; Sandro Sironi
Journal:  J Clin Med       Date:  2022-09-26       Impact factor: 4.964

9.  Mediastinal effusion due to pericardiocentesis with cardiac tamponade: a case report.

Authors:  Qian Zhang; Difen Wang; Ying Liu
Journal:  BMC Anesthesiol       Date:  2021-06-16       Impact factor: 2.217

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.